Log in to save to my catalogue

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d63836c7a114f4dba0a8c801602e18a

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

About this item

Full title

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2023-12, Vol.29 (1), p.74

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

In the absence of a vaccine, there is a need to find new drugs for the treatment of neglected tropical diseases, such as leishmaniasis, that can overcome the many drawbacks of those currently used. These disadvantages include cost, the need to maintain a cold chain, the route of administration, the associated adverse effects and the generation of r...

Alternative Titles

Full title

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5d63836c7a114f4dba0a8c801602e18a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5d63836c7a114f4dba0a8c801602e18a

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules29010074

How to access this item